Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.32 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11798100 | 1.00 | AKR1C4 (0.41) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| SCHEMBL11220260 | 0.86 | AKR1C4 (0.36) | AKR1C4AKR1C3AKR1C2BRD4PTGER3 | |
| SCHEMBL11755975 | 0.84 | AKR1C4 (0.57) | AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL11514658 | 0.80 | AKR1C4 (0.48) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| SCHEMBL29785194 | 0.77 | PTGER2 (0.44) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| SCHEMBL22125386 | 0.77 | PTGER2 (0.44) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| SCHEMBL14764390 | 0.77 | PTGER2 (0.44) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| SCHEMBL2477633 | 0.77 | AKR1C4 (0.51) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| SCHEMBL2477632 | 0.77 | AKR1C4 (0.51) | AKR1C4AKR1C3AKR1C2BRD4PTGER2 | |
| Dihydrojasmonic Acid, Methyl Ester SCHEMBL17517758 | 0.76 | PTGER2 (0.48) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115477581-B | Preparation method of high cis methyl dihydrojasmonate | 安徽金禾合成材料研究院有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-121913912-A | Preparation method of methyl dehydrojasmonate | 山东顺成化学有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-121913912-A | Preparation method of methyl dehydrojasmonate | 山东顺成化学有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-118978439-A | Preparation method of 2- (3-acetoxyl-2-pentylcyclopent-2-en-1-yl) methyl acetate | 山东新和成药业有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-115477581-B | Preparation method of high cis methyl dihydrojasmonate | 安徽金禾合成材料研究院有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-115477581-B | Preparation method of high cis methyl dihydrojasmonate | 安徽金禾合成材料研究院有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-117964485-A | Method for preparing cis (1R, 2S) -methyl dihydrojasmonate by asymmetric catalytic hydrogenation | 上海交通大学 | 2024-05-03 | — | — | CN | disclosed |
| CN-113929575-B | Preparation method of (1R, 2S) -methyl dihydrojasmonate | 上海应用技术大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-115477581-A | Preparation method of high-cis methyl dihydrojasmonate | 安徽金禾化学材料研究所有限公司 | 2022-12-16 | — | — | CN | disclosed |
| US-11332789-B2 | Compositions and methods for diagnosing and treating hyperlipidemia-related diseases | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-05-17 | — | — | US | disclosed |